NebuPent

Active Ingredient(s): Pentamidine
FDA Approved: * June 15, 1989
Pharm Company: * AM PHARM PARTNERS
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



NebuPent Overview

Pentamidine is an antimicrobial medication used to treat African trypanosomiasis, leishmaniasis, babesiosis, and to prevent and treat pneumocystis pneumonia (PCP) in people with poor immune function.[1] In African trypanosomiasis it is used for early disease before central nervous system involvement, as a second line option to suramin.[1] It is an option for both visceral leishmaniasis and cutaneous leishmaniasis.[1] Pentamidine can be given by ...

Read more NebuPent Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pentamidine

Recent NebuPent Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pentamidine
  • For Solution: 300mg/vial, 600mg/vial
  • Injection: 300mg, 300mg/vial
  • Powder for Reconstitution: 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for NebuPent: (1 result)

Sorted by National Drug Code
  • 63323-877 Nebupent 300 mg/6ml Respiratory (Inhalation) Inhalant by App Pharmaceuticals, LLC

Other drugs which contain Pentamidine or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA